Eurogin is part of the Informa Markets Division of Informa PLC


EUROGIN 2023 abstract submission is now open! Submission deadline: October 3, 2022

Message from the Chairman of the Scientific Committee

Dear friends and colleagues,

Since its creation three decades ago, the EUROGIN congress has gained a strong reputation as one of the leading international conferences on HPV infection and associated cancers. The meeting offers a forum for high-level scientific exchange involving multiple disciplines, with the aim to translate research into clinical practice. Thanks to the top-ranking program committee the congress program offers up-to-date scientific information on the full range of HPV-related diseases.

For non-vaccinated populations, early detection and HPV based screening remains to be the key challenge.

The perspective of eliminating HPV infection and related cancers continues to be a major goal. HPV immunization on a large scale opens a priceless opportunity to reduce the burden of cervical, ano-genital and oral cancer all over the world. The journey started some time ago, but the destination has now come into sight: elimination of HPV related cancer.

As usual, the EUROGIN congress will offer a variety of educational opportunities for attendees: training courses, specialized workshops, scientific sessions, clinical sessions, free communications and poster presentations.

On behalf of the EUROGIN Organizing Committee, I am pleased to welcome you to EUROGIN.

Joseph Monsonego

Chairman of the Scientific Committee